NCT03817632View on ClinicalTrials.gov

Orthopilot Elite Post-Market Clinical Follow-Up

CompletedOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

October 29, 2022

Conditions
Degenerative OsteoarthritisRheumatoid ArthritisPosttraumatic ArthropathyInstability, JointStiffness of Knee, Not Elsewhere ClassifiedDeformity of Knee
Interventions
DEVICE

Computer assisted primary total knee replacement with OrthoPilot FS101 navigation system and Software 5.1

Computer Assisted Total Knee Replacement with the OrthoPilot FS101 and the software TKA 5.1

DEVICE

Computer assisted primary total knee replacement with OrthoPilot Elite navigation system and Software 6.0

Computer Assisted Total Knee Replacement with the with the OrthoPilot Elite and the software TKA 6.0

Trial Locations (3)

22081

Schönkliniken Klinikum Eilbek, Hamburg

79106

Uniklinikum Freiburg, Freiburg im Breisgau

01307

Universitätsklinikum Carl Gustav Carus, Dresden

All Listed Sponsors
lead

Aesculap AG

INDUSTRY

NCT03817632 - Orthopilot Elite Post-Market Clinical Follow-Up | Biotech Hunter | Biotech Hunter